ASTRAZENECA PHARMACEUTICALS LP

DE

​Biopharmaceutical Company.

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 18 of its records are shown together here.

Filings
346
Filed By
18
Reported In-House
$73,556,713
Reported By Firms
$10,443,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2026 THOLOS GOVERNMENT RELATIONS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report (No Activity)
$20,000
2026 ASTRAZENECA PHARMACEUTICALS LP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$810,000
2026 W STRATEGIES, LLC 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$80,000
2026 TODD STRATEGY GROUP 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$80,000
2026 THOLOS GOVERNMENT RELATIONS 3rd Quarter (July 1 - Sep 30)
Registration
—
2026 TODD STRATEGY GROUP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$80,000
2026 W STRATEGIES, LLC 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$80,000
2026 ASTRAZENECA PHARMACEUTICALS LP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$1,680,000
2026 ASTRAZENECA PHARMACEUTICALS LP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$2,280,000
2026 TODD STRATEGY GROUP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$80,000
Page 1 of 35  ·  346 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings